BULFAMANTE, SARA
 Distribuzione geografica
Continente #
AS - Asia 1.199
NA - Nord America 1.087
EU - Europa 689
SA - Sud America 41
AF - Africa 28
OC - Oceania 20
Totale 3.064
Nazione #
US - Stati Uniti d'America 1.051
CN - Cina 668
IT - Italia 250
SG - Singapore 148
TW - Taiwan 137
AT - Austria 74
DE - Germania 73
JP - Giappone 61
HK - Hong Kong 60
SE - Svezia 50
FR - Francia 44
GB - Regno Unito 43
BR - Brasile 38
IE - Irlanda 37
KR - Corea 34
UA - Ucraina 22
VN - Vietnam 21
MX - Messico 20
IN - India 18
PL - Polonia 18
AU - Australia 14
CA - Canada 14
CH - Svizzera 11
IR - Iran 10
MA - Marocco 10
RU - Federazione Russa 10
FI - Finlandia 9
ID - Indonesia 8
NL - Olanda 8
TH - Thailandia 8
LU - Lussemburgo 7
NZ - Nuova Zelanda 6
CZ - Repubblica Ceca 5
HU - Ungheria 5
IQ - Iraq 5
PK - Pakistan 5
SN - Senegal 5
TR - Turchia 5
ZA - Sudafrica 5
BE - Belgio 4
EE - Estonia 4
IL - Israele 4
PT - Portogallo 4
ES - Italia 3
MY - Malesia 3
DZ - Algeria 2
EG - Egitto 2
GR - Grecia 2
NG - Nigeria 2
PR - Porto Rico 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BG - Bulgaria 1
CO - Colombia 1
DK - Danimarca 1
KE - Kenya 1
LT - Lituania 1
MD - Moldavia 1
QA - Qatar 1
RO - Romania 1
SI - Slovenia 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 3.064
Città #
Beijing 129
Chandler 116
Taipei 94
Los Angeles 86
Redwood City 71
Vienna 71
Shanghai 67
Guangzhou 65
Singapore 64
Fairfield 57
Santa Clara 56
Torino 43
Ashburn 41
Turin 40
Dublin 37
Ann Arbor 34
Houston 34
Chengdu 30
Woodbridge 29
Shenyang 28
Dearborn 26
Nyköping 25
Wilmington 23
Nanjing 21
Jacksonville 20
Seattle 17
Wuhan 17
Zhengzhou 17
Cambridge 15
Hangzhou 15
Changsha 14
Tokyo 14
Fremont 13
Pisa 13
Columbus 12
Lanzhou 12
Düsseldorf 10
Milan 10
San Diego 10
Dong Ket 9
Jinan 9
Oxford 9
Princeton 9
Xian 9
Boston 8
Central 8
Falkenstein 8
Hong Kong 8
Kaohsiung City 8
Medford 8
New York 8
Palermo 8
Polska 8
Changchun 7
Chongqing 7
Dobong-gu 7
Fuzhou 7
Heidelberg 7
Villeurbanne 7
Detroit 6
Hebei 6
Jakarta 6
London 6
Portland 6
São Paulo 6
Taichung 6
Tianjin 6
Warsaw 6
Bethesda 5
Cape Town 5
Clemson 5
Erlangen 5
Hefei 5
Najaf 5
Nanning 5
San Giovanni Lupatoto 5
San Mateo 5
Seoul 5
Shaan 5
Washington 5
Bangkok 4
Berlin 4
Christchurch 4
Harbin 4
Helsinki 4
Mumbai 4
Munich 4
Napoli 4
Nuremberg 4
Osaka 4
Paris 4
Rome 4
San Francisco 4
Strambinello 4
Sydney 4
Verona 4
Villadose 4
Absecon 3
Boardman 3
Bologna 3
Totale 1.846
Nome #
Alpha-Enolase (ENO1), a potential target in novel immunotherapies 1.723
Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis 295
Next generation immunotherapy for pancreatic cancer: DNA vaccination is seeking new combo partners 196
In pancreatic cancer chemotherapy increases anti-tumor responses to tumor associated antigens and potentiates DNA vaccination 177
Antibody and T cell response profiling of pancreatic cancer patients before and after chemotherapy reveals increased recognition of antigens suitable for immunotherapy 151
Antibody and T cell response profiling in pancreatic cancer patients before and after chemotherapy identify tumor associated antigens suitable for immunotherapy 145
The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer 121
Identification of chemotherapy-induced antigens suitable for immunotherapy in pancreatic cancer patients 109
Discovery of Targets for Cancer Immunoprevention 98
In pancreatic cancer patients, chemotherapy reshapes the gene expression profile and antigen receptor repertoire of T lymphocytes and enhances their effector response to tumor-associated antigens 46
Profiling small RNAs in fecal immunochemical tests: is it possible? 40
Unleashing anti-tumor immune responses in pancreatic cancer by tumor-associated antigens 24
Totale 3.125
Categoria #
all - tutte 6.357
article - articoli 0
book - libri 0
conference - conferenze 1.199
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.556


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202028 0 0 0 0 0 0 0 0 0 0 0 28
2020/2021546 32 40 44 31 53 66 49 36 59 41 38 57
2021/2022477 48 34 45 53 57 45 56 27 6 17 58 31
2022/2023358 24 37 6 40 21 61 14 34 39 21 26 35
2023/2024370 24 27 16 22 104 41 16 21 3 21 40 35
2024/2025507 18 20 42 55 97 48 18 30 63 38 48 30
Totale 3.125